Potential prognostic factors for predicting the chemotherapeutic outcomes and prognosis of patients with metastatic colorectal cancer

被引:18
|
作者
Zhang, Liqun [1 ]
Zhang, Jingdong [1 ]
Wang, Yuanhe [1 ]
Dong, Qian [1 ]
Piao, Haiyan [1 ]
Wang, Qiwei [1 ]
Zhou, Yang [1 ]
Ding, Yang [1 ]
机构
[1] China Med Univ, Liaoning Canc Hosp & Inst, Med Oncol Dept Gastrointestinal Tumors, Canc Hosp, 44 Xiaohe Rd, Shenyang 110042, Liaoning, Peoples R China
关键词
chemotherapy response; colorectal cancer; FAR; PGR; prealbumin; prealbumin to globulin; LONG-TERM SURVIVAL; GLOBULIN RATIO; NEUTROPHIL-LYMPHOCYTE; INFLAMMATORY STATUS; PLASMA-FIBRINOGEN; ALBUMIN; PHARMACOKINETICS; RESECTION; IMPACT; TUMORS;
D O I
10.1002/jcla.22958
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives The purpose of this study was to explore whether pretreatment potential prognostic factors are related to chemotherapeutic outcomes and the prognosis of inpatients with metastatic colorectal cancer (mCRC) undergoing chemotherapy. Materials and methods Data from 71 patients with mCRC were analyzed retrospectively. The relationship between the potential prognostic factors before first-line chemotherapy and the clinicopathological characteristics and chemotherapy response of the patients was calculated using Fisher's exact test and the chi-square test. The prognostic factors were analyzed using univariate and multivariate analyses. We analyzed the subgroups using the Mann-Whitney U test. Results Four factors were eventually used as prognostic factors, namely the albumin-to-globulin ratio (AGR), the fibrinogen-to-albumin ratio (FAR), the prealbumin-to-globulin ratio (PGR), and the fibrinogen-to-prealbumin ratio (FPR); the cutoff values of the four potential prognostic factors were 1.40, 10.63, 5.44, and 18.49, respectively. The high AGR and PGR groups had a higher response rate than that of the low groups. Patients in the low FAR and FPR groups showed a higher objective response rate than the high FAR and FPR groups. Patients with low FPR were associated with a higher disease control rate than patients with high FPR. Higher progression-free survival (PFS) was observed in the high AGR and PGR and low FAR and FPR groups. The AGR, FAR, PGR, and FPR were considered reliable prognostic factors for PFS in a univariate analysis. Conclusions The prechemotherapy AGR, FAR, PGR, and FPR were good prognostic factors to predict the chemotherapy response and PFS in patients with mCRC.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Prognostic factors in metastatic colorectal cancer
    Silva, M.
    Guerreiro, I.
    Abreu, S.
    Marques, D.
    [J]. ANNALS OF ONCOLOGY, 2018, 29
  • [2] Significance of Markers of Systemic Inflammation for Predicting Survival and Chemotherapeutic Outcomes and Monitoring Tumor Progression in Patients with Unresectable Metastatic Colorectal Cancer
    Shibutani, Masatsune
    Maeda, Kiyoshi
    Nagahara, Hisashi
    Ohtani, Hiroshi
    Sakurai, Katsunobu
    Yamazoe, Sadaaki
    Kimura, Kenjiro
    Toyokawa, Takahiro
    Amano, Ryosuke
    Kubo, Naoshi
    Tanaka, Hiroaki
    Muguruma, Kazuya
    Ohira, Masaichi
    Hirakawa, Kosei
    [J]. ANTICANCER RESEARCH, 2015, 35 (09) : 5037 - 5046
  • [3] Thoracoscopic pulmonary metastasectomy in metastatic colorectal cancer: Surgical outcomes and prognostic factors
    Yun, Ju Sik
    Kim, Eunchong
    Na, Kook Joo
    Song, Sang Yun
    Jeong, In Seok
    Oh, Sang Gi
    [J]. THORACIC CANCER, 2021, 12 (19) : 2537 - 2543
  • [4] Metastatic Colorectal Cancer: Prognostic and Predictive Factors
    Nappi, Anna
    Nasti, Guglielmo
    Romano, Carmela
    Berretta, Assimiliano
    Ottaiano, Alessandro
    [J]. CURRENT MEDICINAL CHEMISTRY, 2020, 27 (17) : 2779 - 2791
  • [5] An analysis of prognostic factors in patients with synchronous and metachronous metastatic colorectal cancer
    Tei, Mitsuyoshi
    Ohtsuka, Masahisa
    Suzuki, Yozo
    Kishi, Kentaro
    Tanemura, Masahiro
    Akamatsu, Hiroki
    [J]. CANCER SCIENCE, 2018, 109 : 1358 - 1358
  • [6] The pretreatment albumin to globulin ratio predicts chemotherapeutic outcomes in patients with unresectable metastatic colorectal cancer
    Shibutani, Masatsune
    Maeda, Kiyoshi
    Nagahara, Hisashi
    Ohtani, Hiroshi
    Iseki, Yasuhito
    Ikeya, Tetsuro
    Sugano, Kenji
    Hirakawa, Kosei
    [J]. BMC CANCER, 2015, 15
  • [8] The pretreatment albumin to globulin ratio predicts chemotherapeutic outcomes in patients with unresectable metastatic colorectal cancer
    Masatsune Shibutani
    Kiyoshi Maeda
    Hisashi Nagahara
    Hiroshi Ohtani
    Yasuhito Iseki
    Tetsuro Ikeya
    Kenji Sugano
    Kosei Hirakawa
    [J]. BMC Cancer, 15
  • [9] Prognostic factors in metastatic pancreatic cancer: Older patients have poorer prognosis
    Ciftci, R.
    Karabulut, S.
    Aydogan, F.
    Kilic, L.
    Keskin, S.
    Yildiz, I.
    Vatansever, S.
    Tas, F.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S601 - S601
  • [10] An immune-related gene prognostic index for predicting prognosis in patients with colorectal cancer
    Li, Chao
    Wirth, Ulrich
    Schardey, Josefine
    Ehrlich-Treuenstaett, Viktor V.
    Bazhin, Alexandr V.
    Werner, Jens
    Kuehn, Florian
    [J]. FRONTIERS IN IMMUNOLOGY, 2023, 14